-
Natrecor “Dear Doctor” Letter Seeks to Address Recent Safety Concerns
Letter Includes New Natrecor Label Revised in April 2005 Natrecor is a treatment, administered by injection, for patients with acutely decompensated congestive heart failure (ADHF) with dyspnea. Recent reports in medical journals have raised…
-
Medication Errors in Hospitals Involve Pharmacy-dispensing Errors in Estimated 10-20% of Incidents
Drug Name Confusion is a Common Cause of Drug-related Errors A medication error is generally defined as a deviation from the prescription drug order written by the prescribing physician on the patient’s chart. In…
-
Toxic Epidermal Necrolysis (TEN) is Usually Due to Adverse Drug Reaction
Patients with Toxic Epidermal Necrolysis (TEN) Often Have Fatal Outcome Toxic epidermal necrolysis (TEN) is an infrequent, yet often fatal, severe systemic and cutaneous disease that is most often the result of an adverse…
-
FDA Revises Their Web Site for Easier Use by Patients Looking for Prescription Drug Safety Information
New "Core Page" Provides a Gateway to FDA Drug Safety Information The FDA has begun a revision its web site in order to give patients easier access to all FDA information for a specific…
-
FDA’s Adverse Event Reporting System (AERS) Needs Improvement
Reports of Potential Drug Side Effects by Physicians, Pharmacists, Patients, and Manufacturers The Adverse Event Reporting System, or AERS, is the FDA’s system to monitor potential side effects of a prescription drug after it…
-
Drug-induced Liver Injury Most Frequent Reason for Drug Recall
Adverse Drug Reactions are Primary Cause of Acute Liver Failure in U.S. Drug-induced liver injury is the most frequent reason cited for the withdrawal from the U.S. market of an FDA-approved prescription drug. Relatedly,…
